Medication info
TruDa Tablet 5 mg (Dapagliflozin bis L-Proline)

TruDa Tablet 5 mg (Dapagliflozin bis L-Proline)

Prescription medicationTabletOral
Ingredient · strength
Dapagliflozin Bis L-proline›7.815mg / 1 tablet
Manufacturer / importer
Boryung Pharmaceutical Co., Ltd.
Appearance
A yellow, biconvex, round film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202500734 · Approved 2025.03.31 · Insurance code 641908660

Summary

Main use
Improvement of type 2 diabetes mellitus, inhibition of worsening chronic heart failure, inhibition of worsening chronic kidney disease
Who takes it
Adults · Children
Adult dose
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received antidiabetic drug therapy, the recommended initial dose of this medicine when administered in combination with metformin is 5mg once daily or 10mg once daily. Chronic heart failure and chronic kidney disease The recommended dose of this medicine is 10 mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - eGFR less than 25 mL/min/1.73m2: Initiation of this medicine is not recommended in patients with chronic heart failure and chronic kidney disease. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be taken orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
Child dose
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Ingredients

Manufacturer
Boryung Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of type 2 diabetes mellitus, inhibition of worsening chronic heart failure, inhibition of worsening chronic kidney disease

  • Type 2 diabetes
  • blood sugar control disorders
  • cardiovascular disease
  • cardiovascular risk factors
  • chronic heart failure
  • heart failure
  • chronic kidney disease
  • reduced glomerular filtration rate
  • end-stage kidney disease
View approved original text

This medication is used alongside diet and exercise to help control blood sugar levels in patients with type 2 diabetes. It is also effective in reducing the risk of death and hospitalization due to cardiovascular disease in patients with chronic heart failure. Additionally, it plays a role in reducing the risk of deterioration of kidney function in patients with chronic kidney disease. This drug may be used in combination with other standard treatments for diabetic patients with cardiovascular risk factors. Overall, this drug helps improve major health issues in patients with diabetes, heart failure, and kidney disease.

How to take

Adult dose

Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received antidiabetic drug therapy, the recommended initial dose of this medicine when administered in combination with metformin is 5mg once daily or 10mg once daily. Chronic heart failure and chronic kidney disease The recommended dose of this medicine is 10 mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - eGFR less than 25 mL/min/1.73m2: Initiation of this medicine is not recommended in patients with chronic heart failure and chronic kidney disease. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be taken orally once daily at any time of day, with or without food. The tablet should be swallowed whole.

Child dose

The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Precautions

This medication should not be used in patients with allergies to the active ingredient or excipients. It should not be administered to patients with type 1 diabetes or diabetic ketoacidosis. Because this drug contains anhydrous lactose, it should not be used in patients with lactose intolerance or certain genetic metabolic disorders. Patients undergoing dialysis should also not be given this medication. Patients with reduced fluid volume or kidney function issues should use this drug with caution, and fluid status and kidney function should be closely monitored before and after administration. In patients with moderate to severe renal impairment, the blood sugar control effect of this drug may be reduced, and it is not recommended for patients with severe renal impairment. During treatment with this medication, genital infections and urinary tract infections may occur, so immediate treatment should be sought if infection symptoms appear. There is a risk of hypoglycemia, so dose adjustments may be needed when used with medications that may induce hypoglycemia, such as insulin or sulfonylureas. Fluid volume reduction or symptoms of hypotension may occur, so caution is required, particularly in elderly patients or those on diuretics. This medication may increase the risk of diabetic ketoacidosis; therefore, immediate consultation with healthcare professionals should be sought if symptoms or signs of ketoacidosis appear. Pregnant or breastfeeding women are advised not to use this medication, and if pregnancy is confirmed, use should be discontinued. Safety and efficacy in children have not been established, and it should not be used in pediatric patients. In cases of overdose, there is no specific antidote; appropriate treatment should be given based on symptoms, and hospital management may be required as necessary. This medication does not significantly affect driving or machine operation, but caution is needed when there is a risk of hypoglycemia. The product should be kept out of the reach of children and stored in its original container to maintain quality.

Side effects

Vulvovaginitis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal necrosis, hypoglycemia, decreased fluid volume, thirst, diabetic ketoacidosis, dizziness, constipation, dry mouth, back pain, dysuria, polyuria, nocturia, interstitial nephritis, vulvar pruritus, genital pruritus, increased hematocrit, decreased initial renal creatinine clearance, dyslipidemia, elevated serum creatinine at the beginning of treatment, increased blood urea, weight loss, rash, angioedema, urosepsis, pyelonephritis, acute kidney injury, renal dysfunction, asthenia, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral artery occlusion, angina pectoris, myocardial infarction, choledocholithiasis, cholangitis, alcoholic liver cirrhosis, depression, suicide attempt, gastric adenocarcinoma, anaphylactic reaction, acute pyelonephritis, chest pain, chronic gastritis, diverticulosis, pneumoperitoneum, frequent bowel movements, gastroenteritis, colon polyps, bowel perforation, epigastric discomfort, functional dyspepsia, erosive gastritis, gingival disorders, gum pain, hemorrhoids, hiatal hernia, irritable bowel syndrome, melena, chronic pancreatitis, urgency, diabetic nephropathy, overactive bladder, microalbuminuria, stress urinary incontinence, urinary hesitancy, urolithiasis, abnormal urination, increased blood lactate, lymphocytopenia, weight gain, vitamin D deficiency, increased appetite, dysgeusia, drowsiness, tension headache, carpal tunnel syndrome, cerebral infarction, diabetic neuropathy, coma, nerve compression, neuralgia, peripheral neuropathy, sleep disturbances, syncope, tremors, bronchitis, shingles, sinusitis, tonsillitis, stye, joint abscess, laryngitis, otitis media, pelvic inflammatory disease, pericoronitis, pneumonia, pulmonary tuberculosis, rhinitis, onychomycosis, herpes simplex, edema, fever, foreign body sensation, facial swelling, facial pain, warmth, flu-like syndrome, breast mass, erectile dysfunction, benign prostatic hyperplasia, mastalgia, genital rash, menorrhagia, genital swelling, uterine bleeding, vaginal bleeding, vulvar discomfort, irregular menstruation, pruritus, urticaria, diaphoresis, arthralgia, musculoskeletal pain, limb pain, muscle weakness, myalgia, osteoarthritis, ligament sprain, diabetic retinopathy, cough, dyspnea, orthostatic hypotension, palpitations, insomnia, fatty liver, gallbladder polyp, tinnitus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly closed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1°C and 30°C at room temperature.

Appearance and packaging

Appearance

A yellow, biconvex, round film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.